← Back to Screener
COMPASS Pathways Plc American Depository Shares (CMPS)
Price$9.46
Favorite Metrics
Price vs S&P 500 (26W)43.51%
Price vs S&P 500 (4W)69.01%
Market Capitalization$639.93M
All Metrics
Book Value / Share (Quarterly)$0.39
P/TBV (Annual)2.20x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.64
Price vs S&P 500 (YTD)33.17%
EPS (TTM)$-3.03
10-Day Avg Trading Volume6.25M
EPS Excl Extra (TTM)$-3.03
EPS (Annual)$-3.08
ROI (Annual)-83.91%
Cash / Share (Quarterly)$1.56
ROA (Last FY)-136.85%
EBITD / Share (TTM)$-1.86
ROE (5Y Avg)-51.83%
Cash Flow / Share (Annual)$-1.64
P/B Ratio17.02x
P/B Ratio (Quarterly)14.63x
Net Income / Employee (Annual)$-2
Net Interest Coverage (TTM)-1.49x
ROA (TTM)-106.75%
EPS Incl Extra (Annual)$-3.08
Current Ratio (Annual)0.77x
Quick Ratio (Quarterly)0.69x
3-Month Avg Trading Volume2.92M
52-Week Price Return202.24%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.09
52-Week High$10.21
EPS Excl Extra (Annual)$-3.08
26-Week Price Return50.40%
Quick Ratio (Annual)0.69x
13-Week Price Return29.41%
Total Debt / Equity (Annual)0.20x
Current Ratio (Quarterly)0.77x
Enterprise Value$521.956
Revenue / Employee (Annual)$0
Cash / Share (Annual)$1.56
3-Month Return Std Dev124.00%
Net Income / Employee (TTM)$-2
ROE (Last FY)-100.28%
Net Interest Coverage (Annual)-0.68x
EPS Basic Excl Extra (Annual)$-3.08
Total Debt / Equity (Quarterly)0.83x
EPS Incl Extra (TTM)$-3.03
ROI (TTM)-141.00%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$4.25
Price vs S&P 500 (52W)167.60%
Year-to-Date Return37.10%
5-Day Price Return64.52%
EPS Normalized (Annual)$-3.08
ROA (5Y Avg)-64.52%
Month-to-Date Return71.07%
Cash Flow / Share (TTM)$-2.58
EBITD / Share (Annual)$-1.86
LT Debt / Equity (Annual)0.16x
ROI (5Y Avg)-47.37%
LT Debt / Equity (Quarterly)0.49x
EPS Basic Excl Extra (TTM)$-3.03
P/TBV (Quarterly)1.58x
P/B Ratio (Annual)1.67x
Book Value / Share (Annual)$2.26
Price vs S&P 500 (13W)27.03%
Beta2.43x
Revenue / Share (TTM)$0.00
ROE (TTM)-172.50%
52-Week Low$2.25
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CMPSCOMPASS Pathways Plc American Depository Shares | — | — | — | — | $9.46 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Compass Pathways is a mental health company developing psilocybin-based therapies for treatment-resistant depression (TRD), a severe form of major depressive disorder with limited existing treatment options. The company's approach combines its proprietary high-purity psilocybin formulation (COMP360) with psychological support to create a comprehensive treatment model. By targeting an underserved patient population, Compass addresses a significant unmet medical need in mental health care.